Apremilast receives FDA approval for treatment of oral ulcers associated with Behçet’s Disease

July 19, 2019
Celgene Corporation announced the FDA has approved apremilast 30 mg twice daily for adults with oral ulcers associated with Behçet’s Disease…
In the Journals

1 in 4 early-middle-aged adults has osteopenia

July 19, 2019
More than 25% of early-middle-aged adults had osteopenia in their neck, according to findings recently published in the Journal of the American
Profile

Corrona: Leveraging 'Big Data' for Improved Patient Outcomes

July 19, 2019
Most scientists, by nature and by training, are in one business: Observe a knowledge gap, and fill it. With that in mind, in 2001, the founders of…
In the Journals

Tocilizumab suitable alternative to TNF inhibitors in DMARD-naïve patients with RA

July 18, 2019
Tocilizumab, in monotherapy or in combination with conventional synthetic DMARDs, is an adequate alternative to combination therapy with a TNF…
Editorial

Direct-to-consumer Ads and the Rheumatologist: Time for Value-based Care Approach

Healio Rheumatology, July 2019
Leonard H. Calabrese, DO
One of the best parts of penning my monthly editorials for Healio Rheumatology is the opportunity to let the spirit move me on occasion. This month…
Cover Story

A Clearer Clinical Picture: Exploring Shifts in Use, Cost of Diagnostic Imaging

Healio Rheumatology, July 2019
New technology entering the medical field often portends a number of positive developments: Improved diagnosis and management of a disease; faster or…
In the Journals

IBD risk increases with Enbrel therapy for other autoimmune diseases

July 18, 2019
Patients receiving Enbrel for inflammatory diseases other than inflammatory bowel disease have an increased risk for a diagnosis of Crohn’s…

FDA offers tips on advising patients how to dispose of unneeded medications

July 18, 2019
Proper disposal of unused prescription medication remains a major public health priority for the FDA, particularly for prescription opioid pain
In the Journals

Biological DMARDs linked to higher bone mass, strength in PsA

July 18, 2019
Patients with psoriatic arthritis who received biological DMARDs demonstrate better bone mass and strength than those treated with methotrexate or no…
In the Journals

Nephritis, clinical trials top list of childhood lupus research priorities

July 17, 2019
Nephritis, clinical trials and biomarkers rank highest among research priorities related to childhood-onset systematic lupus erythematosus, according…
In the Journals

Nearly 30% of patients with gout prescribed opioids after ED visit

July 17, 2019
Despite available treatments, more than 28% of patients with gout who are discharged from the ED receive opioids for pain, according to data…
In the Journals

Baricitinib improves RA in patients unresponsive to methotrexate

July 16, 2019
Baricitinib monotherapy improves disease control in many patients with rheumatoid arthritis who were did not respond to methotrexate, according to…
In the Journals

Lower estrogen exposure linked to increased risk for Sjögren's syndrome in women

July 16, 2019
Primary Sjögren’s syndrome in women is associated with lower estrogen exposure and cumulative menstrual cycling, according to data published in…
In the Journals

EULAR stresses privacy, transparency in research using 'big data'

July 15, 2019
Rheumatic and musculoskeletal disorders researchers should consider the ethical issues surrounding privacy, confidentiality, identity and…
In the Journals

Lower stress predicts significant pain improvement in fibromyalgia

July 15, 2019
Reduced stress levels, and high pain intensity at baseline, predict an increased likelihood of significantly improved pain after 10 to 12 years among…
Meeting News

Opioids’ negative consequences extend to patients with migraine, expert says

July 14, 2019
PHILADELPHIA — The benefits of prescribing opioids to patients with migraines usually do not outweigh the risk, a past president of the…

$1.4 billion lawsuit, largest against opioid manufacturer, settles before trial

July 12, 2019
A lawsuit filed against London-based Reckitt Benckiser Group plc was recently settled for $1.4 billion, the largest settlement to date against an…
Origin Stories

All the President's Secrets: John F. Kennedy and Addison's disease

July 12, 2019
It is no secret that America, like so many other countries and cultures, has long been obsessed with vitality and youth. It is easy to think that…
In the JournalsPerspective

Positive framing improves patients’ willingness to switch to biosimilar

July 11, 2019
Although patients express concerns regarding the safety and efficacy of biosimilars, physicians can improve willingness to switch to a biosimilar by…
In the Journals

Greater hip BMD gains seen with denosumab vs. teriparatide after long-term bisphosphonate use

July 11, 2019
Long-term bisphosphonate users who switched to the human monoclonal antibody denosumab experienced a gain in hip bone mineral density in the first…